Topoisomerase 2 Alpha Cooperates with Androgen Receptor to Contribute to Prostate Cancer Progression

Open Access

Peer-reviewed

Research Article

J. L. Schaefer-Klein,

Affiliations Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, United States of America, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Stephen J. Murphy,

Affiliations Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, United States of America, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Sarah H. Johnson,

Affiliation Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
George Vasmatzis,

Affiliations Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, United States of America, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Irina V. Kovtun

* E-mail: Kovtun.Irina@mayo.edu

Affiliations Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
⨯

Reader Comments (0)

Prostate cancer
Is the Subject Area "Prostate cancer" applicable to this article?

Thanks for your feedback.
Cloning
Is the Subject Area "Cloning" applicable to this article?

Thanks for your feedback.
Androgens
Is the Subject Area "Androgens" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Toxins
Is the Subject Area "Toxins" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
DNA repair
Is the Subject Area "DNA repair" applicable to this article?

Thanks for your feedback.